National News

April 2018 Price Concessions/NCSO – 2nd update

PSNC News - 24 April 2018 - 5:00pm

Department of Health and Social Care (DHSC) has today granted the following list of price concessions:

Drug Pack size Price Concession Aripiprazole 10mg tablets 28 £3.05 Bicalutamide 150mg tablets 28 £16.94 Co-codamol 30mg/500mg capsules 100 £4.50 Glimepiride 1mg tablets 30 £2.22 Irbesartan 150mg tablets 28 £5.12 Irbesartan 75mg tablets 28 £2.40 Mirtazapine 15mg orodispersible tablets 30 £1.50 Mirtazapine 45mg orodispersible tablets 30 £2.00 Oxybutynin 5mg tablets 56 £1.87 Perindopril erbumine 2mg tablets 30 £4.13 Perindopril erbumine 4mg tablets 30 £3.30 Perindopril erbumine 8mg tablets 30 £5.85 Pioglitazone 30mg tablets 28 £14.85 Topiramate 50mg tablets 60 £9.50 Venlafaxine 75mg tablets 56 £5.68

DHSC previously (19.04.2018) granted the following price concessions:

Drug Pack size Price Concession Amitriptyline 50mg tablets 28 £2.88 Aripiprazole 5mg tablets 28 £2.85 Aripiprazole 15mg tablets 28 £3.22 Bicalutamide 50mg tablets 28 £17.24 Chlorpromazine 50mg tablets 28 £32.47 Lacidipine 2mg tablets 28 £2.95 Lansoprazole 15mg orodispersible tablets 28 £2.98 Oxybutynin 2.5mg tablets 56 £1.11 Phenoxymethylpenicillin 125mg/5ml oral solution 100ml £5.96 Phenoxymethylpenicillin 250mg/5ml oral solution 100ml £7.43 Ramipril 2.5mg tablets 28 £1.04 Trimethoprim 200mg tablets 6 £0.40 Trimethoprim 50mg/5ml oral suspension sugar free 100ml £3.75

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated April 2018 Drug Tariff price.  Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

 

Categories: National News

Health & Care Review

PSNC News - 24 April 2018 - 4:50pm

Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and LPCs stay up to date, PSNC provides this update service outlining the latest information in an easily digestible format. Weekly updates are published on our website and contractors can ensure they do not miss them by signing up to PSNC’s email newsletter service here.

The reviews extend the work we have been doing for some time to help LPCs stay informed about the NHS changes, and they inform the more detailed PSNC briefings which we continue to publish on this topic; these can be accessed in the Healthcare Landscape section of the website.

People growing older with learning disabilities should get regular health checks, says NICE

The National Institute for Health and Care Excellence (NICE) has published new guidance which advises that health and social care workers help organise regular health assessments for older people with learning difficulties because they may find it difficult to express their needs and be heard. The guideline describes how to help people with learning disabilities as they grow older to ensure they receive appropriate support at the right times, preventing delays in care.

Older people with learning disabilities are more likely to develop serious health problems and die of them because of late diagnosis. They may also find it more difficult to access health services because of hearing or sight problems.

NICE is advising that annual health checks are recorded in a ‘health action plan’ that can be updated annually. This personalised plan details what help and support the individual needs to stay healthy and provides other information about support needs and lifestyle issues. The guideline also advises local authorities to ensure there are opportunities for people growing older with learning disabilities to socialise and be active in their communities.

The state of care in independent acute hospitals

The Care Quality Commission (CQC) has published the findings of an inspection programme for 206 independent acute hospitals in England in 2015.

CQC found that the majority of acute hospitals are providing high quality care for patients; as of January 2018, 62% were rated as good and 8% were rated as outstanding.

However, while the report highlights many examples of good care, it also shows variation in quality and clear scope for improvement. CQC had the greatest concerns about safety and found that 41% of hospitals were rated as requires improvement and 1% as inadequate in this area. In some cases, CQC found that a lack of formalised governance procedures meant that hospitals were not effectively monitoring the work of consultants and inspectors also saw that safety procedures were not always fully embedded.

The findings from these inspections have helped to inform CQC’s plans to further develop its approach to regulation for all independent healthcare services.

Women and HIV: Invisible No Longer

The Terrence Higgins Trust has launched a new report in collaboration with Sophia Forum to highlight the needs of women affected by Human Immunodeficiency virus (HIV).

Key facts highlighted include:

  • women make up one third of people living with HIV in the UK, yet are left out of research, decision-making, service design and delivery;
  • almost half of women living with HIV in the UK live below the poverty line;
  • nearly one third have avoided or delayed attending healthcare in the past year due to fear of discrimination; and
  • on HIV prevention, little effort has been made to define who women at risk of HIV are. Nearly half the respondents (42%) felt that barriers prevent them from testing for HIV, and no woman surveyed had yet chosen to access PrEP.

The two organisations are calling for gender parity in the UK HIV response, specifically address women’s need in research, HIV prevention, data collection and support services.

Prostate Cancer: Britain’s Growing Problem

A male cancer charity, Orchid, has published a new report which highlights a trend in late prostate cancer diagnoses and calls for urgent action to be taken.

The report reveals that:

  • 37% of prostate cancer cases are diagnosed in the late stages (stages 3 and 4);
  • 42% of prostate cancer patients saw their GP with symptoms twice or more before they were referred;
  • 23% of all cancer cases are diagnosed through A&E, with the majority of these cases at late stage; and
  • Prostate cancer cases are set to rise dramatically over the next decade.

Recommendations for urgent action by policy makers to address Britain’s growing prostate cancer problem include:

  • public awareness of symptoms by Public Health England and local authorities;
  • healthcare professionals’ adherence to treatment standards;
  • improved diagnostic tests introduced by NHS England; and
  • continuation of investment and development for research into diagnostic testing and patient risk profiling.
Changes to QOF 2018/19

NHS Employers and the British Medical Association’s General Practitioner Committee agreed changes to the Quality and Outcomes Framework (QOF) effective from 1st April 2018.

The key changes are:

  • the average practice list size had risen from 7,732 as at 1 January 2017 to 8,096 at 1 January 2018;
  • The value of a QOF point will increase by £8.06 from £171.20 in 2017/18 to £179.26 in 2018/19;

QOF indicators and thresholds for 2018/19 continue unchanged.

Developing new models of care in the PACS vanguards: a new national approach to large-scale change?

NHS England has commissioned the King’s Fund to publish a report as part of a package of support provided to primary and acute care system (PACS) vanguard sites. The report features the accounts of those who have led the development of the PACS model, nationally and locally, to reflect on the process. It is not evaluation of the PACS model but rather offers insights and experiences of those leading a major programme at the national level and those living it at the local level.

Key messages include:

  • national bodies can support large-scale change in the health and care system by acting as catalysts of locally led innovation;
  • in the PACS vanguard sites, relatively modest transformation funding has helped to catalyse significant amounts of innovation in terms of both frontline services and wider structures supporting system-wide collaboration;
  • relationships were strengthened in vanguard sites and this needs to happen before more formal changes to contractual arrangements or organisational structures are considered;
  • spreading and scaling-up innovations from the vanguards sites is the challenge to which system leaders are now turning; and
  • further work is needed at the national level to remove legal, regulatory and financial barriers that inhibit integrated working across organisational boundaries.
Allied Health Professions (AHPs) supporting patient flow

NHS Improvement and NHS England have published a quick guide to demonstrate how NHS emergency care, in particular patient flow through the health and care system, benefits from allied health professionals (AHPs). Each section gives a brief overview of the contribution AHPs can make to safe, effective patient care and flow, followed by case studies.

Less waste, more health: A health professional’s guide to reducing waste

The Royal College of Physicians has published a report which explains how health professionals can positively influence societal health and wellbeing by making simple changes to procurement and disposal of medical supplies.

The report features a range of case studies and offers 12 practical recommendations on waste management, principles of purchasing and cultural influence to positively influence the health of patients, aid financial savings and shape the impact of the NHS on the environment.

Integrated Commissioning for Better Outcomes: a commissioning framework 2018

The Local Government Association and NHS Clinical Commissioners in partnership with the Department of Health and Social Care, Association of Directors Adult Social Services, Think local Act Personal and Care Providers Alliance has published the Integrated Commissioning for Better Outcomes Framework 2018. This is a practical tool for council and NHS commissioners to support improving outcomes through integrated commissioning. The framework covers four areas:

  • building the foundations;
  • taking a person-centred, place-based and outcomes-focused approach;
  • shaping provision to support people, places and populations; and
  • continuously raising the ambition.

The tool was developed from the Commissioning for Better Outcomes Framework 2015 and has been updated to better reflect the changing commissioning landscape.

The standards are designed to support a dynamic process of continuous improvement and can be used:

  • to support cross-organisational reflection and dialogue on how well integration in local commissioning arrangements are working;
  • as a benchmarking diagnostic tool in critical self-assessment by system partners; and
  • in a peer to peer review or peer challenge to promote sector led improvement.
 Faster action needed on lessons of WannaCry attack

The Public Accounts Committee has published a report on the WannaCry cyber-attack on the NHS in May 2017. The attack caused widespread disruption to health services with almost 20,000 hospital appointments and operations cancelled and five accident and emergency departments diverting patients as they were unable to treat them.

The report indicates how the Department of Health and Social Care (DHSC) and its arm’s-length bodies were unprepared for the relatively unsophisticated cyber-attack. Whilst DHSC and NHS bodies have learned lessons the report indicates that there is still work to do to improve cyber-security.

The Committee has set six recommendations to be met with a progress update by a June 2018 deadline that include DHSC and its national bodies to:

  • consider and agree implementation plans setting out a clear timetable that has clear roles, responsibilities and oversight arrangements at both local and national level;
  • set out clear coordinated communications during a cyber-attack;
  • support local organisations to improve cyber security and be ready for a cyber-attack;
  • provide a national estimate of the cost to the NHS of WannaCry and an update on costed plans for vital security investment;
  • provide guidance and support for local systems to be updated; ensure IT suppliers to the NHS are accredited and that local and national workforce plans include a focus on IT and cyber skills; and
  • make cyber security a priority and work with wider government to share lessons and promote best practice.
Patients get the green light for smarter choices after latest GP pilot

NHS England has published new trial results from the Behavioural Insights Team on a pilot system which makes it easier for GPs to understand hospital waiting times for their patients.

The e-traffic light system could help reduce hospital waiting times while offering patients a clearer choice of treatment and is set to be rolled out across the country after a successful NHS trial.

A tweak to the GP referral system sees a red light appear against a hospital with longer waiting times while a green light shows those with spare capacity, meaning doctors can offer patients potentially quicker routes to treatment and help them make more informed choices.

Results from two London trials have been promising – red lights reduced referrals to overbooked hospitals by nearly 40%, while green lights increased referrals to hospitals with available capacity by 14% this winter.

Media monitoring

On Monday 16th April 2018, the following stories were published:

  • NHS hospitals are owed around £139 million from health tourists who have failed to pay for their treatment in England, reports The Mail.
  • The Telegraph reports on research that suggests women taking common painkillers during pregnancy could make their grandchildren infertile. Also reported by The Mail and the BBC.
  • ‘GP at Hand’ app cuts off patients from regular NHS doctor, reports the Times. Tens of thousands of people have downloaded the ‘GP at Hand’ app which offers remote consultations with doctors, however when they sign up they are removed from their GP’s books and registered to a practice in west London.
  • The Mail reports that obesity is set to take over alcohol as the leading cause of liver disease in the next few years.

On Tuesday 17th April 2018, the following stories were published:

  • The Independent reports that there has been a significant increase in violence against NHS staff, especially in the hospitals with the longest waiting lists. Also covered by The Mail.
  • The Taxpayers’ Alliance claims that the NHS could save £800 million a year by reducing the number of bodies which perform very similar functions, reports The Mail and The Sun.
  • The Times reports that experts think school children should be taught about nutrition and healthy eating to help them grow up to be better parents. This is similar to several stories saying that having an unhealthy lifestyle prior to becoming a parent can still impact on the children you have later. Covered by The Independent, The Telegraph, iNews and ITV News.

On Thursday 19th April 2018, the following story was published:

  • The Guardian reports that almost two-thirds of healthcare assistants are performing roles usually undertaken by nurses due to the NHS staffing crisis.

On Friday 20th April, the following stories were published:

  • The BBC and The Mail pick up the story about more patients having multiple conditions. The BBC reports that researchers say that being a patient is now ‘a full time job’, whilst The Mail says that these patients typically receive worse care.
  • GP Online report that the majority of GP practices reported cuts to public health funding. 77% of the 250 GP partners who responded to the survey reported that funding had been withdrawn or reduced for at least one public health service their practice provides. Smoking cessation, sexual health and weight management services were among those most affected, GPs said.
  • ITV News reports that Chief Medical Officer Dame Sally Davies is warning that ignoring antibiotics misuse could led to the end of modern medicine.
  • Dementia patients are nearly 20% more likely to be given unnecessary prescriptions due to difficulties with communication, reports The Mail. Taking these unnecessary drugs can then increase dementia patients’ risk of suffering falls due to sedation and drowsiness.

 

Categories: National News

Valproate licence change: important information for pharmacy teams

PSNC News - 24 April 2018 - 10:45am

The Medicines and Healthcare products Regulatory Agency (MHRA) has changed the licence for valproate medicines (Epilim, Depakote and generic brands) so it must no longer be prescribed to women or girls of childbearing potential unless they are on the Pregnancy Prevention Programme (PPP).

This is because valproate is associated with a significant risk of birth defects and developmental disorders in children born to women who take valproate during pregnancy. The change in licencing is to make sure patients are fully aware of the risks and the need to avoid becoming pregnant.

The PPP includes the completion of a signed risk acknowledgement form when their treatment is reviewed by a specialist, at least annually. All women and girls who are prescribed valproate should contact their GP and arrange to have their treatment reviewed. No woman or girl should stop taking valproate without medical advice.

These regulatory changes will be further supported in the upcoming months by:

  • smaller pack sizes to encourage monthly prescribing; and
  • a pictogram/warning image on valproate labelling.

For further information including an MHRA toolkit and links to patient support networks, please visit the GOV.UK website.

Categories: National News

MHRA Drug Safety Update – April 2018

PSNC News - 24 April 2018 - 10:08am

Date issued: 24th April 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 9, April 2018) has been published and includes articles on:

  • valproate medicines (Epilim▼, Depakote▼): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met;
  • obeticholic acid (Ocaliva▼): risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment; reminder to adjust dosing according to liver function monitoring; and
  • suspect an adverse reaction? Yellow Card it!

To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.

Categories: National News

PSNC Statement on Community Pharmacy Funding Negotiations

PSNC News - 23 April 2018 - 2:50pm

Community pharmacy contractors and LPCs may be aware that the All-Party Pharmacy Group (APPG) has today made a statement on the upcoming negotiations on community pharmacy funding.

This follows communication between Sir Kevin Barron MP, who is Chair of the All-Party Pharmacy Group (APPG), and the Pharmacy Minister Steve Brine.

The Minister said he had been very interested in the APPG’s work hearing evidence on community pharmacy and the management of long-term conditions and he noted PSNC’s proposals for the development of community pharmacy services.

PSNC discussed proposals for the future of the Community Pharmacy Contractual Framework at its January meeting and these were put to the Department of Health and Social Care (DHSC) and NHS England. Further details on PSNC’s proposals can be found below.

PSNC has not yet received a mandate for the negotiations on funding for the 2018/19 financial year from NHS England and the DHSC, but hopes these discussions will begin soon.

PSNC Chief Executive Sue Sharpe said:

“PSNC’s ambition is to move to a funding framework that fairly rewards community pharmacies for offering a wide range of patient care and services including the dispensing of medicines. This is in line with the sector’s shared vision for its future, and would include allowing pharmacies to offer more patient care, particularly for people with long-term conditions.

The Minister has given no detail on what the substance of our negotiations with the DHSC and NHS England for 2018/19 will be, but we hope that we will be able to have substantive discussions on the future of community pharmacy. Given the very difficult financial situation that many community pharmacy contractors now find themselves in it is vital that we start to make meaningful progress towards achieving the sector’s vision.”

PSNC’s Proposals

PSNC’s proposals were intended to provide a possible mechanism to move towards a community pharmacy funding arrangement that fairly rewards community pharmacies for providing more patient care and support for people with long-term conditions.

The documents below set out the proposals in more detail.

Community Pharmacy: Developing Services for the Future
This briefing outlines PSNC’s proposals. Whilst it was created to explain PSNC’s proposals to external stakeholders, those working in community pharmacy may also find it a useful summary.

Introducing the Universal Community Pharmacy Care Framework
An infographic describing the Care Framework.

Community Pharmacy Care Plan: The Patient Journey
An infographic describing the support a patient could receive from their community pharmacy as part of the Care Plan.

PSNC Proposals for Community Pharmacy Contractual Framework (CPCF) Developments
This Powerpoint presentation sets out PSNC’s proposals for developing the CPCF, covering how they were developed, the changes they would bring to community pharmacy and how we are taking them forward.

Categories: National News

The Mary Seacole Leadership programme – further cohorts open for applications

PSNC News - 20 April 2018 - 2:06pm

With investment from the Pharmacy Integration Fund, the Centre for Pharmacy Postgraduate Education (CPPE) collaborated with the NHS Leadership Academy in 2017 to offer the Mary Seacole programme to pharmacists and pharmacy technicians working in community pharmacy. There are now further opportunities to access the Mary Seacole programme available for booking in 2018 across England.

This programme is NHS-led and designed to develop leadership and management skills to drive quality services in community pharmacy. Participation on the programme will enable you to:

  • Have increased self-awareness of how the changes you make can have an impact on colleagues in the NHS and the people you serve
  • Recognise your own personal value to healthcare and embed behaviours that improve the patient experience
  • Learn how to enable others to be the best they can be in the workplace through effective teamwork

It is a six-month long programme, which includes three face to face meetings, to prepare participants for the demands of leadership in the healthcare system today, and into the future.

To access further information or register on the programme, please read through the information on the CPPE website.

Categories: National News

NHS turns 70: primary care event

PSNC News - 20 April 2018 - 12:42pm

2018 marks 70 years since the NHS came into being and events are being planned throughout the year to celebrate this milestone.

As part of the ‘NHS70’ celebrations, NHS England is running a 10-day event to highlight the role of primary care in the NHS, and community pharmacy teams are encouraged to join in. Between 20th and 30th April there will be a range of social media activity, driven by local NHS England teams, using the #NHS70 and #primarycare hashtags.

Anyone working in the community pharmacy sector is invited to help promote pharmacy’s contribution to NHS primary care both today, and over the past 70 years. We would love to see pharmacy teams tweeting their own experiences of working in NHS primary care and PSNC has created a set of tweet templates to help inspire you.

NHS70 tweet templates

Further digital resources, planned by NHS England, include:

  • A film montage about changing roles for clinicians in primary care;
  • Clinical pharmacy quotes as part of a series of infographics​ on Twitter;
  • A video blog (or ‘vlog’) by the chief professional officers; and
  • A blog by Chief Pharmaceutical Officer Dr Keith Ridge about a visit to Westbourne Medical Centre in Bournemouth.

These digital assets will be made available to share between 20th and 30th April from www.england.nhs.uk/nhs70/spotlight-series/primary-care, as well as via NHS England’s Twitter, Facebook and YouTube accounts.

Looking for more ways pharmacy teams can get involved with the NHS70 celebrations? Click here for ideas.

Categories: National News

Service case study: Community pharmacies tackle inequalities for patients with psychosis

PSNC News - 20 April 2018 - 10:16am

A community pharmacy service, Improving Physical Health Care for People with Psychosis (PHCP), has been highlighted by the Royal College of Psychiatrists as an example of good practice using Quality Improvement methodologies to improve patient outcomes.

The project, which took place in Barking and Dagenham, was a joint collaboration between North East London LPC, North East London NHS Foundation Trust (NELFT) and University College London, with support from Public Health London Borough of Barking and Dagenham and the London Mental Health Strategic Clinical Network. It was funded by a Health Foundation Innovation Award and ran from September 2016 to January 2018.

What did the service involve?

Patients with a diagnosis of psychotic illness, known to the Barking and Dagenham Community Recovery Team, were offered physical health checks at a local participating community pharmacy. This included ECG, blood pressure, cholesterol and glucose testing with results available on the same day. Pharmacists spent up to an hour coaching patients and empowering them to self-manage their physical health.

What were the results of the project?

There were 350 patients eligible for the service; of these, 180 were offered health checks and 140 attended the health check with 78% who were offered the health checks taking up the offer. Additionally, 70% of attendees had all five Lester cardiometabolic risk factors monitored which is a higher rate of patient uptake compared to the NHS England national inpatient and national community setting averages. This is significantly better than standard care in Barking and Dagenham, where only 36% of patients had all five risk factors monitored.

All patients attending community pharmacy health checks had health coaching to support them with physical health, in comparison to 44% of patients receiving standard care in Barking and Dagenham.

There were:

  • 22 patients who received support to stop smoking;
  • 56 patients who received support for exercise; and
  • 78 patients who received support to eat healthier or lose weight.

The project team and NELFT are now considering how to implement the PHCP model across the four London Boroughs within the Trust’s area.

Click here to view a YouTube video on the project

Dr Asif Bachlani, Consultant Psychiatrist said: ‘It has been a great privilege to work with community pharmacies on NEL LPC on this innovative project which aims to tackle the health inequalities faced by patients with psychosis who have often faced barriers to have their physical health monitored.  This project is an example of new models of care which uses a partnership model between secondary and primary care which breaks down the barriers of traditional care models by being able to meet the needs of this vulnerable and often forgotten group of patients by based in the local community’.

Hemant Patel, NEL LPC, Secretary, said: ‘Pharmacists provide high quality and accessible care from local pharmacies which was very much appreciated by this vulnerable patient group. The carers, too, appreciated local support and need for avoiding going to hospital or clinic and using public transport. Pharmacists enjoyed the training and patient contact which improved their consultation skills and feeling of contribution to their community.

Categories: National News

Getting to grips with GDPR – 2. Have a plan!

PSNC News - 20 April 2018 - 10:10am

This article has been written by Gordon Hockey, PSNC Director of Operations and Support, and is the second in a series of articles for contractors about the General Data Protection Regulation (GDPR) and the associated (currently draft) UK Data Protection Act 2018 (DPA 2018), which both come into force on 25th May 2018. The articles accompany the  GDPR guidance and contractor workbook

Once you’ve started to get to grips with GDPR (see Part 1. Where do I start?), it’s important to have a plan and consider what needs to be done. The Community Pharmacy GDPR Working Party has developed a 13-step plan, followed by both the guidance and the workbook. The steps are set out in the form of a mnemonic – DATAPROTECTED – to help you to remember them, as follows:

  1. Decide who is responsible
  2. Action plan
  3. Think about and record the personal data you process
  4. Assure your lawful basis for processing
  5. Process according to data protection principles
  6. Review and check with your processors
  7. Obtaining consent if you need to
  8. Tell people about your processes: the Privacy Notice
  9. Ensure data security
  10. Consider personal data breaches
  11. Think about data subject rights
  12. Ensure privacy by design and default
  13. Data protection impact assessment

If you follow this 13-step plan, this should assist you on your journey towards GDPR compliance.

Your plan you should also include staff training. Staff need to be trained appropriately to their roles and should understand the basics of data protection (knowledge they should have already) and be aware of the GDPR and some of its key issues for your pharmacy, for example:

  • you have a lawful basis for processing data concerning health, a special category of personal data;
  • you have a privacy notice and they need to bring this to the attention of new patients;
  • data security is very important, and they are involved in this too (and exactly how);
  • generally, subject access requests are dealt with without charge and within in one calendar month; and,
  • there are new rules on dealing with data protection breaches and the Information Commissioner’s Office (ICO) may need to be informed of a breach without undue delay and at least within 72 hours of you first becoming aware of it.

Your registration with the ICO also remains important and you will need to continue to pay a fee to the ICO after 25th May 2018 (there are some exemptions from this requirement).

This has the feeling of a revision plan, which is perhaps appropriate as we head towards the summer exams for many students.

For more information and guidance on GDPR, please visit psnc.org.uk/GDPR

Categories: National News

April 2018 Price Concessions/NCSO – 1st update

PSNC News - 19 April 2018 - 5:00pm

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack size Price Concession Amitriptyline 50mg tablets 28 £2.88 Aripiprazole 5mg tablets 28 £2.85 Aripiprazole 15mg tablets 28 £3.22 Bicalutamide 50mg tablets 28 £17.24 Chlorpromazine 50mg tablets 28 £32.47 Lacidipine 2mg tablets 28 £2.95 Lansoprazole 15mg orodispersible tablets 28 £2.98 Oxybutynin 2.5mg tablets 56 £1.11 Phenoxymethylpenicillin 125mg/5ml oral solution 100ml £5.96 Phenoxymethylpenicillin 250mg/5ml oral solution 100ml £7.43 Ramipril 2.5mg tablets 28 £1.04 Trimethoprim 200mg tablets 6 £0.40 Trimethoprim 50mg/5ml oral suspension sugar free 100ml £3.75

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated April 2018 Drug Tariff price.  Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

Categories: National News

Dispensing & Supply monthly update (April 2018)

PSNC News - 19 April 2018 - 11:51am

This briefing is part of a series issued regularly by PSNC to inform pharmacy contractors and pharmacy teams on monthly Drug Tariff changes, commonly asked questions and articles regarding dispensing and supply.

This briefing can also be found in the Dispensing & Supply section of April’s CPN.

PSNC Briefing 024/18: Dispensing & Supply monthly update (April 2018)

If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.

To browse other PSNC briefings on dispensing and supply click here.

View Article…

Categories: National News

Class 4 MHRA drug alert – Inhixa solution for injection in pre-filled syringe

PSNC News - 18 April 2018 - 5:00pm

Drug alert number: EL (18)A/07

Date issued: 18th April 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for:

Inhixa solution for injection in pre-filled syringe 2,000 IU (20 mg) in 0.2 mL; 4,000 IU (40 mg) in 0.4 mL; 6,000 IU (60 mg) in 0.6 mL; 8,000 IU (80 mg) in 0.8 mL; 10,000 IU (100 mg) in 1.0 mL (Techdow Europe AB)

Marketing Authorisation number:

  • EU/1/16/1132/012
  • EU/1/16/1132/014
  • EU/1/16/1132/016
  • EU/1/16/1132/018
  • EU/1/16/1132/020

Techdow Europe AB has issued this Direct Healthcare Professional Communication (DHCP) due to rare cases of premature self-activation of the safety device in unused, unopened pre-filled Inhixa syringes as shown in the DHCP diagrams. When premature activation has occurred, administration is not possible.

To minimise the risk of missed doses:

  • Pharmacists should visually check all Inhixa syringes before dispensing to check if they are affected by the self-activation defect as shown in the DHCP diagrams. Do not open the syringe blisters.
  • Individual syringes that are affected by the self-activation defect should not be dispensed to patients.
  • Pharmacists should make sure they have sufficient stock of Inhixa available as replacements.

Techdow Pharma England Limited can be contacted on 01271 334 609.

To view the alert please visit the GOV.uk website.

 

Categories: National News

Drug Tariff Watch: May 2018 changes

PSNC News - 18 April 2018 - 2:05pm

The Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of the changes due to take place from 1st May 2018.

Part VIIIA additions

Category A:

•   Imatinib 100mg tablets (60)

Category C:

•   Acetylcysteine 2g/10ml solution for infusion ampoules (10) – Martindale Pharmaceuticals Ltd
•   Adrenaline (base) 150micrograms/0.3ml (1 in 2,000) solution for injection pre-filled disposable devices SC (1) and (2) – EpiPen Jr.
•   Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 0.4ml unit dose preservative free (30 (6xSC5)) – Ganfort
•   Cefuroxime 125mg/5ml oral suspension R (70ml) – Zinnat
•   Diltiazem 120mg modified-release capsules (28) – Adizem-XL
•   Diltiazem 120mg modified-release capsules (56) – Adizem-SR
•   Diltiazem 180mg modified-release capsules (28) – Adizem-XL
•   Diltiazem 180mg modified-release capsules (56) – Adizem-SR
•   Diphtheria / Tetanus / Poliomyelitis (inactivated) vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes SC (1) – Revaxis
•   Enoxaparin sodium 300mg/3ml solution for injection vials SC (1) – Clexane
•   Estradiol 500micrograms / Dydrogesterone 2.5mg tablets (84) – Femoston-conti
•   Glucose powder for oral use BP 1980 (500g) – Thornton & Ross Ltd
•   Hepatitis A (inactivated) / Hepatitis B (rDNA) vaccine (adsorbed) suspension for injection 1ml pre-filled syringes SC (1) – Ambirix
•   Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices (3) – Xultophy
•   Insulin lispro biphasic 50/50 100units/ml suspension for injection 3ml cartridges (5) – Humalog Mix50
•   Insulin soluble human 100units/ml solution for injection 3ml cartridges (5) – Humulin S
•   Methotrexate 12.5mg/0.5ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Methotrexate 15mg/0.6ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Methotrexate 17.5mg/0.7ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Methotrexate 20mg/0.8ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Methotrexate 22.5mg/0.9ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Methotrexate 25mg/1ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Methotrexate 7.5mg/0.3ml solution for injection pre-filled syringes SC (1) – Zlatal
•   Nifedipine 20mg modified-release tablets (28) – Adalat LA
•   Nifedipine 20mg modified-release tablets (56) – Adalat retard
•   Somatropin (rbe) 10mg powder and solvent for solution for injection vials SC (1) – Zomacton
•   Somatropin (rbe) 4mg powder and solvent for solution for injection vials SC (1) – Zomacton
•   Somatropin (rmc) 8mg powder and solvent for solution for injection vials SC (1) – Saizen
•   Timolol 2.5mg/ml eye drops preservative free SC (5ml) – Eysano
•   Timolol 5mg/ml eye drops preservative free SC (5ml) – Eysano
•   Ulipristal 5mg tablets (28) – Esmya

Part VIIIA amendments

•   Imatinib 400mg tablets (30) – Glivec is changing to Category A
•   Pramipexole 1.05mg modified-release tablets (30) – Mirapexin is changing to Category A
•   Pramipexole 1.57mg modified-release tablets (30) – Mirapexin is changing to Category A
•   Pramipexole 260microgram modified-release tablets (30) – Mirapexin is changing to Category A
•   Pramipexole 2.1mg modified-release tablets (30) – Mirapexin is changing to Category A
•   Pramipexole 2.62mg modified-release tablets (30) – Mirapexin is changing to Category A
•   Pramipexole 3.15mg modified-release tablets (30) – Mirapexin is changing to Category A
•   Pramipexole 520microgram modified-release tablets (30) – Mirapexin is changing to Category A

Part VIIIA deletions

•   Emulsifying ointment 50% / Liquid paraffin 50% ointment (100g) – Emulfin

Part IX deletions

It is important to take careful note of removals from Part IX because if you dispense a deleted product, prescriptions will be returned as disallowed

Product Type, Size and Product Code WOUND MANAGEMENT
DRESSINGS – Tielle Xtra Square (11cm x 11cm and 15cm
x 15cm) and Rectangular (15cm
x 20cm) URINAL SYSTEMS – Bard Ltd – Maguire adaptor & tubing 600532 BELTS – AMI Medical Ltd –
Corsinel Suportx Abdominal
Tube, White X Small (74-82cm) – CRL243W
Small (78-90cm) – CRL244W
Medium (86-98cm) – CRL245W
Large (94-106cm) – CRL246W
X Large (102-116cm) – CRL247W

Want to learn more about recent Dispensing & Supply news? Read our monthly updates here.

Categories: National News

April edition of CPN magazine now available

PSNC News - 18 April 2018 - 12:54pm

The April 2018 edition of PSNC’s Community Pharmacy News (CPN) is now available. This month’s CPN features:

  • Pharmacy funding levels maintained – interim arrangements agreed to protect current funding distribution systems prior to negotiations
  • Getting to grips with GDPR
  • Care Plan evaluation
  • Prescription penalty resources

View our CPN magazine online via the flipbook reader below or download the PDF copy. Please note, the colour PDF can be printed out in black-and-white and will still be clear to read.

Categories: National News

CPPE Corner: A person-centred approach to clinical medical reviews e-course

PSNC News - 17 April 2018 - 5:17pm

The latest e-course from the Centre for Pharmacy Postgraduate Education (CPPE) focuses on taking a person-centred approach to clinical medication reviews.  We spoke to Michelle Styles, CPPE’s Regional Manager for London, to find out more.

Booking is now open for CPPE’s latest e-course, beginning on Monday 23rd April 2018. Clinical medication review: a person-centred approach has been developed to equip you with the clinical knowledge required to identify medicines issues and make clinical decisions based on key information and a patient’s ideas, concerns and expectations.

This 12-week e-course is suitable for pharmacy professionals working in any sector of practice, particularly those working in community pharmacy. Focused weekly topics and the opportunity for clinical discussions through online forums ensures that you can provide person-centred care at all times.

Clinical medication review supports the aims of the NHS Medicines Value Programme, to ensure that medicines are used to achieve better outcomes for patients, and that people are given the support to take their medicines as intended. As pharmacy professionals, you are well placed to help patients get the best and most appropriate choice of medicine and to improve the quality of prescribing.

Each week of Clinical medication review: a person-centred approach will focus on a key priority area for medicines optimisation, as well as a number of ‘reading weeks’ to accommodate busy working periods and allowing those undertaking the course to reflect on and consolidate the previous weeks’ learning.

Completion of the e-course will provide you with an appropriate level of clinical judgement and skills required to provide prioritised recommendations to a prescriber resulting from a clinical medication review, taking into account the patient’s ideas, concerns and expectations.

For more information and to book a place on the Clinical medication review: a person-centred approach e-course visit the overview page on the CPPE website.

 

Categories: National News

Trimovate cream supply issue

PSNC News - 17 April 2018 - 5:00pm

PSNC has become aware that the licensed Trimovate Cream manufactured by Ennogen Healthcare Ltd is currently unavailable. To meet patient need, Ennogen has launched Trimovate Cream as an imported medicine available via Alliance Healthcare Distribution. To enable prescribers to issue EPS or paper prescriptions for the unlicensed Trimovate cream, a new listing has been created on dm+d for ‘Clobetasone 0.05% / Oxytetracycline 3% / Nystatin 100,000units/g cream (Special Order)’.

In order for pharmacy contractors to be paid correctly for dispensing the unlicensed Trimovate cream, prescriptions must read ‘Clobetasone 0.05%/Oxytetracycline 3%/Nystatin 100,000units/g cream (Special Order)’. Prescriptions ordering the licensed ‘Trimovate cream’ will continue to be priced by an exception handler stream as an unlicensed special. In both cases, prescriptions will need to be endorsed as per the usual endorsing guidance for unlicensed specials and imports not listed in the Drug Tariff (non-Part VIIIB) to include the following:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied; and
  • SP.

As a reminder, all prescriptions for unlicensed medicines should be placed in the red separators for the end of month submission.

Please contact Ennogen Healthcare Ltd on +44 (0) 1322 629 220 or info@ennogen.com for further information.

Categories: National News

NHS mandate 2018/19 (April 2018)

PSNC News - 17 April 2018 - 11:22am

Every year, the Department of Health and Social Care (DHSC) issues a mandate to NHS England, to set out the Government’s objectives and requirements for NHS England to deliver, as well as its budget. It helps to set the direction for the NHS and to ensure the NHS is accountable to Parliament and the public.

This PSNC Briefing summarises the elements of the NHS mandate 2018/19 that are of most relevance to community pharmacy contractors and Local Pharmaceutical Committees.

PSNC Briefing 023/18: NHS mandate 2018/19

If you have any queries on this PSNC Briefing or you require more information, please contact Zainab Al-Kharsan, Service Development Pharmacist.

To browse other PSNC briefings on services and commissioning click here.

View Article…

Categories: National News

Dispensing errors legislation comes into force

PSNC News - 16 April 2018 - 5:15pm

Legal defences will be available for inadvertent errors made by community pharmacists and pharmacy technicians from today (16th April 2018).

The Pharmacy (Preparation and Dispensing Errors – Registered Pharmacies) Order 2018 makes provision for a defence to prosecution under section 63 and section 64 of the Medicines Act 1968 in cases where medicines are prepared or dispensed by a registered pharmacist, or registered pharmacy technician, or someone acting under the supervision of a registered pharmacy professional.

The conditions of the defence for the sale or supply of a medicine are that:

  • The medicine must have been dispensed at a registered pharmacy; and
  • The person who dispensed the medicine was a registered pharmacist or registered pharmacy technician acting in the course of their profession or other person acting under their supervision; and
  • The medicine was sold or supplied to fulfill a prescription or direction by a relevant prescriber or a PGD or a POM sold or supplied where there was an immediate need for it (i.e. a prescription could not have been obtained without undue delay); and
  • That one of the following is met:
    • The person who dispensed the medicine did not know that the medicine was not of the required nature or quality (i.e. had no knowledge that the medicine was inappropriate); or
    • Before the person who dispensed the medicine was charged, “an appropriate person” on becoming aware that the medicine was not of the required nature or quality promptly ensured that all reasonable steps were taken to notify the person to whom the medicine was intended or reasonably formed the view that it was not necessary or appropriate to do so and the person who dispensed the medicine did not know at the time of sale or supply of the medicine that it was not of the required nature or quality.

PSNC Director of Operations and Support, Gordon Hockey, said:

“Pharmacies have been required to record patient safety incidents in an incident log and report these to the National Reporting and Learning Service (NRLS) since 2005, but now pharmacy professionals can be reassured that when they do report these incidents, generally they don’t need to fear legal repercussion for making inadvertent errors. PSNC welcomes this legal protection which we hope will allow the profession to instead focus on ensuring that safeguards are in place to minimise errors and identify areas for improvement.”

 

Categories: National News

GDPR webinar now on-demand

PSNC News - 13 April 2018 - 5:57pm

More than 600 people tuned in to PSNC’s recent webinars on complying with the General Data Protection Regulation (GDPR) and community pharmacy contractors can now access an online recording.

During each webinar PSNC Director of Operations and Support, Gordon Hockey, explained what the GDPR means for the average pharmacy business, outlined the steps contractors will need to take to comply, and highlighted the templates that PSNC has developed as part of the cross-sector GDPR working group.

Watching this 60-minute webinar will help you make sure you understand what GDPR means for your pharmacy.

Click here to view an on-demand version of one of the webinars.

Please note, to watch the recording, you will need to register (or input the email address you registered with previously).

Some of the feedback we have received so far:

“I thought it was well presented. Just at the right pace and not too much detail, with the emphasis on what is important and how it affects day to day Pharmacy.”
Director/Owner

“It gave a nice insight into what is a very complex and important topic, yet taken lightly by many.”
Superintendent Pharmacist

“Very relevant and focus was on what to do not just what GDPR is. Thank you.”
Director/Owner

Categories: National News

Health & Care Review

PSNC News - 13 April 2018 - 12:02pm

Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and LPCs stay up to date, PSNC provides this update service outlining the latest information in an easily digestible format. Weekly updates are published on our website and contractors can ensure they do not miss them by signing up to PSNC’s email newsletter service here.

The reviews extend the work we have been doing for some time to help LPCs stay informed about the NHS changes, and they inform the more detailed PSNC briefings which we continue to publish on this topic; these can be accessed in the Healthcare Landscape section of the website.

Accountable care models contract: proposed changes to regulations

The Department of Health and Social Care (DHSC) has published the full outcome of a consultation which took place between September and November 2017 on the proposed changes to regulations to support the development of NHS England’s Accountable Care Organisation (ACO) contract model. The consultation specifically asked consultees to consider whether the draft regulations delivered the policy objective of the introduction of a model ACO contract.

The full outcome report sets out specific issues raised, an analysis of the responses received, a response to concerns raised, and changes made to draft amendments as a result of comments received.

DHSC has also published an accompanying brief guide to ACOs which covers what they are, what they mean for patients and staff, how they will be implemented and whether or not they will lead to more private sector involvement in the NHS.

One in six people with diabetes discriminated against at work

Diabetes UK has published research findings which highlight that a third of people living with diabetes experience a lack of support and understanding from colleagues in the workplace. Additionally, people with diabetes feel that they have been discriminated against by their employer as a result of their condition.

The survey also found that:

  • 37% of respondents said that living with diabetes had caused them difficulty at work;
  • 7% had not told their employer that they have diabetes; and
  • 25% of people said they would like time off work for diabetes-related appointments and flexibility to take regular breaks for testing their blood sugar or to take medication.

Helen Dickens, Assistant Director of Campaigns and Mobilisation at Diabetes UK, said: “Discrimination and difficulties come about because employers lack knowledge about diabetes and do not understand its impact. We need to talk more about the condition and the many ways it affects people’s lives in order to persuade places of work to offer greater understanding and flexibility. Everyone deserves to work in an environment where they can ask for the support they need.”

Dedicated GP support for nursing homes sees significant drop in emergency admissions

The Nuffield Trust has published a study which evaluates a new GP service offering seven-day support to four nursing homes. The service was piloted in the Barking & Dagenham and Havering & Redbridge Clinical Commissioning Groups (CCG) and involves providing GP support as well as training and advice for care home workers and help from a geriatrician.

Key facts from the evaluation include:

  • after registering with the service, emergency inpatient admissions fell by 36% compared to 4% reductions in the comparator group;
  • the authors estimate that the monetary value of reductions in emergency admissions could be as much as £1000 per person per year, but that this is not necessarily directly equivalent to actual cash savings for either commissioners or providers;
  • emergency bed days in the intervention group reduced by 53% compared to no change in the comparator group; and
  • the biggest reductions in emergency admissions and bed days happened towards the end of people’s lives.

The success of the new primary care service in care homes in general, the report authors suggest, depends on the quality and continuity of relationships developed between the GPs and the care homes.

RCGP advises patients on online consultation safety

The Royal College of General Practitioners have issued a list of questions for patients, GPs and commissioners to consider before using online GP services, as part of a new guidance document, Online consultations in general practice: the questions to ask.

The guidance has been issued as it emerged that a growing number of services are offering consultations online, most commonly via smartphone apps.

The questions are:

  1. Will they see me whatever my health problem, or exclude me if I have complex health needs?
  2. Will they have access to my full medical record, so that they know my medical history?
  3. What happens if I need to see a GP in person – how far will I need to travel?

The guidance also outlines considerations for GPs or CCGs considering using or implementing online consultation services for their patients or local populations.

New funding for sports prosthetics for children with disabilities

The Government has announced that children with limb loss will benefit from a new £1.5 million investment into sports and activity prosthetics such as running blades. The fund will also support research and innovation to improve prosthetic technology.

PM announced new research and funding in drive to fight prostate cancer

The Prime Minister has unveiled new plans to get thousands of men with prostate cancer access to earlier and faster treatment. Over the next five years, over 40,000 men will be recruited into prostate cancer studies backed by £75 million funding.

22 Million people encouraged to embrace self care for life

The Self Care Forum has published a review of Self Care Week 2017 as well as findings from a survey of participants of the campaign. The 2017 theme of Embracing Self Care for Life allowed promotion of a range of self-care messages, supported by a range of resources for people-facing organisations.

The review found that more than 300 organisations participated in the campaign, with a combined reach of more than 22 million people – more than a third of the English population.

The survey found that self-care for self-treatable conditions was the most popular message being communicated, and signposting to the community pharmacist was the second most favoured.

Review into NHS overseas visitor charges: call for submissions

DHSC is evaluating the impact of its regulations on NHS charges to overseas visitors that came into effect in 2017 and is asking organisations to share information or experiences to help shape the review.

The review will look at the impact on: upfront charging; amending patient records; community services; and non-NHS providers. It will focus on the impact on vulnerable groups (such as those with protected characteristics) and how any identified negative effects can be addressed.

Does the public see tax rises as the answer to NHS funding pressures?

The King’s Fund has analysed the latest data from the British Social Attitudes survey on public attitudes to NHS funding and the quality of care provided by the NHS. In general, the analysis shows that the public is increasingly anxious about the state of the NHS and there is widespread support for tax increases to fund it.

Key findings include:

  • there is growing consensus that the NHS is facing major crisis; respondents saying that the NHS is facing a funding problem have increased by 14% since 2014;
  • 61% of respondents support tax rises; an increase of 21% from 2014 and 12% from 2016;
  • in relation to tax increases, 35% supported a separate tax that would go direct to the NHS and 26% would pay more through their existing taxes; and
  • pessimism about the future has increased significantly; just 20% expected standards of care to improve.
Patient Activation Measure – implementation quick guide

NHS England has published a quick guide on Patient Activation Measures (PAM) to support sites considering using the PAM license.

The guide covers preparatory work, how to ensure good quality data and how the PAM can ensure that plans for services and support are tailored to an individual’s needs. It also focusses on why patient activation is important in managing people’s health and wellbeing.

Media monitoring

On Monday 9th April 2018 the following stories were published:

  • Tens of thousands of allergy patients face ‘life or death situations’ because of a UK shortage of EpiPen jabs, reports the Mail. US manufacturer Mylan has warned pharmacists and patients in Britain that the country is the latest to be hit by global supply problems. Also featured in the Telegraph and Sun.
  • British tourists will be putting their health at danger when the NHS axes travel vaccinations for rabies and yellow fever, reports the Mail. Experts believe the change could lead to an increase in people obtaining the vaccines via a private prescription and attempting to self-administer to save costs.
  • Four in ten prostate cancer cases diagnosed late, reports the BBC. A study by charity Orchid found a ‘worrying trend’ of late diagnosis with 37% of prostate cancer cases diagnosed at stages three and four. Also featured in the Times, Sun, Mail and Huffington Post.

On Tuesday 10th April 2018 the following stories were published:

  • Deceased organ donor numbers have reached a record high, reports iNews. Latest figures show there were 1,575 deceased donors during 2017/18, an 11% increase on the previous year. A new Bill which would introduce the opt-out system in England passed its first stage in Parliament in February. Also featured in the Times, Mirror, Sun, Huffington Post and the BBC.
  • Patients aged over 60 who lose weight should be investigated, reports the Telegraph. One in seven cases among men likely to mean cancer, a major study has found. Also featured in the Sun, Mail, Times and Express.

On Wednesday 11th April 2018 the following stories were published:

  • The Times reports elderly patients effectively age 10 years for every 10 days they are stuck in a hospital bed due to inactivity. This has also been covered by The Telegraph and The Mail.
  • The Guardian reports that two-fifths of private hospitals in England fail to meet the expected safety standards, according to the Care Quality Commission. This is of concern not just to private patients, but also those given NHS funding to be seen privately. Also covered by iNews, the Independent, Times and BBC.
  • Pfizer UK have a piece in The Telegraph about access to medicines in the NHS. It’s largely focused on treatments for cancer and vaccines.
  • The Sun warns that a new killer flu strain is on its way, but the World Health Organisation has said it will be included in this year’s four-strain flu vaccine.

On Thursday 12th April 2018 the following stories were published:

  • The Telegraph reports that the NHS has launched a sexual abuse probe amid fears of dangers on mixed sex wards. Inspectors have warned hospital trusts to do more to protect patients, amid fears patients are being put at risk on mixed sex wards.
  • iNews reports that a 50% rise in cigarette prices ‘will save millions of poorer people’.
  • A new study suggests that a substantial increase in cigarette prices would help millions of people around the world avoid poor health and extreme poverty. Also featured in the Sun, Mail and Telegraph.
  • Late risers at increased risk of early death, reports the BBC. People who go to bed late and struggle to wake in the morning are more likely to die prematurely than early risers, according to new research. Also featured in the Telegraph.

On Friday 13th April 2018 the following stories were published:

  • The Sun discloses the NHS’s ten worst-performing A&E wards. Following the announcement that A&E waiting times are at their worst level since records began, the ten worst offenders have been revealed. Similar stories are featured in the Mail, ITV, Express and Times.
  • Just one alcoholic drink a day could shorten your life, reports the BBC. An analysis of 600,000 drinkers found that drinking 5 to 10 alcoholic drinks a week was likely to shorten a person’s life by up to six months. Also featured in the Express, Evening Standard, Independent and Telegraph.

Categories: National News
Syndicate content